NDAORALCAPSULE, DELAYED REL PELLETS
Approved
Aug 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
9
Data completeness
3/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Cymbalta (duloxetine HCl) is an oral delayed-release small-molecule SNRI (serotonin-norepinephrine reuptake inhibitor) approved in 2004. It treats major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain, and chemotherapy-induced peripheral neuropathy. The drug works by inhibiting reuptake of serotonin and norepinephrine in the central nervous system.
LOE Approaching
As LOE approaches, the brand team is likely consolidating resources and transitioning from growth to lifecycle management strategies, requiring expertise in retention and generic barrier-building.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (9)
A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta
Started Mar 2020
0Healthy
A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions
Started Mar 2020
0Healthy
The Cymbalta Pregnancy Registry
Started Jul 2009
144 enrolled
Pregnancy
Cymbalta for Depression as a Complication of Bereavement
Started Apr 2008
20 enrolled
DepressionBereavement
Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients
Started Jul 2006
269 enrolled
Pain
Worked on CYMBALTA at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.